搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Trichophyton rubrum Probable neutral protease 2 homolog B (NpII-B) CSB-YP496109TQA
CSB-EP496109TQA
CSB-BP496109TQA
CSB-MP496109TQA
CSB-EP496109TQA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles hirsuta Sphingomyelin phosphodiesterase D LhSicTox-alphaIA2aiv CSB-YP496110LQZ
CSB-EP496110LQZ
CSB-BP496110LQZ
CSB-MP496110LQZ
CSB-EP496110LQZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles hirsuta Sphingomyelin phosphodiesterase D LhSicTox-alphaIA2biii CSB-YP496111LQZ
CSB-EP496111LQZ
CSB-BP496111LQZ
CSB-MP496111LQZ
CSB-EP496111LQZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles spadicea Sphingomyelin phosphodiesterase D LspaSicTox-alphaIA2iv CSB-YP496112LRF
CSB-EP496112LRF
CSB-BP496112LRF
CSB-MP496112LRF
CSB-EP496112LRF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles apachea Sphingomyelin phosphodiesterase D LapSicTox-alphaIB2 CSB-YP496113LQV
CSB-EP496113LQV
CSB-BP496113LQV
CSB-MP496113LQV
CSB-EP496113LQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles sabina Sphingomyelin phosphodiesterase D LsaSicTox-alphaIB2ii CSB-YP496114LRD
CSB-EP496114LRD
CSB-BP496114LRD
CSB-MP496114LRD
CSB-EP496114LRD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles apachea Sphingomyelin phosphodiesterase D LapSicTox-alphaIB1aiv CSB-YP496115LQV
CSB-EP496115LQV
CSB-BP496115LQV
CSB-MP496115LQV
CSB-EP496115LQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles arizonica Sphingomyelin phosphodiesterase D LarSicTox-alphaIB1c CSB-YP496116LQW
CSB-EP496116LQW
CSB-BP496116LQW
CSB-MP496116LQW
CSB-EP496116LQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles deserta Sphingomyelin phosphodiesterase D LdSicTox-alphaIB1aiv CSB-YP496117LQY
CSB-EP496117LQY
CSB-BP496117LQY
CSB-MP496117LQY
CSB-EP496117LQY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles deserta Sphingomyelin phosphodiesterase D LdSicTox-alphaIB3av CSB-YP496118LQY
CSB-EP496118LQY
CSB-BP496118LQY
CSB-MP496118LQY
CSB-EP496118LQY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles sabina Sphingomyelin phosphodiesterase D LsaSicTox-alphaIB1aiii CSB-YP496119LRD
CSB-EP496119LRD
CSB-BP496119LRD
CSB-MP496119LRD
CSB-EP496119LRD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles variegata Sphingomyelin phosphodiesterase D LvSicTox-alphaIC1ai CSB-YP496120LRH
CSB-EP496120LRH
CSB-BP496120LRH
CSB-MP496120LRH
CSB-EP496120LRH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles variegata Sphingomyelin phosphodiesterase D LvSicTox-alphaIC1biv CSB-YP496121LRH
CSB-EP496121LRH
CSB-BP496121LRH
CSB-MP496121LRH
CSB-EP496121LRH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles rufescens Sphingomyelin phosphodiesterase D LruSicTox-alphaIC1a CSB-YP496122LRC
CSB-EP496122LRC
CSB-BP496122LRC
CSB-MP496122LRC
CSB-EP496122LRC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles sp. Sphingomyelin phosphodiesterase D Ls4SicTox-alphaIII1i CSB-YP496123LRE
CSB-EP496123LRE
CSB-BP496123LRE
CSB-MP496123LRE
CSB-EP496123LRE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles hirsuta Sphingomyelin phosphodiesterase D LhSicTox-alphaIV2 CSB-YP496124LQZ
CSB-EP496124LQZ
CSB-BP496124LQZ
CSB-MP496124LQZ
CSB-EP496124LQZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles laeta Sphingomyelin phosphodiesterase D LlSicTox-alphaIV3 CSB-YP496125LRB
CSB-EP496125LRB
CSB-BP496125LRB
CSB-MP496125LRB
CSB-EP496125LRB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sicarius peruensis Sphingomyelin phosphodiesterase D SpeSicTox-betaIB1b CSB-YP496126SZI
CSB-EP496126SZI
CSB-BP496126SZI
CSB-MP496126SZI
CSB-EP496126SZI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles spinulosa Sphingomyelin phosphodiesterase D LspiSicTox-betaIE4i CSB-YP496127LRG
CSB-EP496127LRG
CSB-BP496127LRG
CSB-MP496127LRG
CSB-EP496127LRG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles aff. spinulosa Sphingomyelin phosphodiesterase D LafSicTox-betaIE1 CSB-YP496128LQT
CSB-EP496128LQT
CSB-BP496128LQT
CSB-MP496128LQT
CSB-EP496128LQT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>